Sight Sciences
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4040 Campbell Ave Ste 100, Menlo Park, C...Phone Number
(877) 266-1144Website
www.sightsciences.comRevenue
$83.4 MillionStock Symbol
SGHTIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Sight Sciences
Sight Sciences Inc. is an ophthalmic medical device company. It engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company was founded in 2010 and is headquartered in Menlo Park, California.Explore more
Sight Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sight Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Sight Sciences
Click to see if Sight Sciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Sight Sciences recently announced quarterly report
Check if Sight Sciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Sight Sciences launches new products
Sight Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Sight Sciences has new funding data
Check out if Sight Sciences is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Sight Sciences
Compare insights from companies similar to Sight Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sight Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sight Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sight Sciences.
Sight Sciences financials insights
Gather financial insights about Sight Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$6.9M
2016
Series B
$7M
2017
Series C
$10M
2019
Series D
$31M
2020
Stock Offering
$30M
Debt
$2M
2021
Series E
$30M
2024
Debt
$65M
Sight Sciences Tech Stack
A closer look at the technologies used by Sight Sciences
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Earnings
Sight Sciences has reported total operating expenses of $25.3 million for Q2 2026, a decrease of 11% compared to $28.3 million in the prior year period, with Adjusted Operating Expenses of $22.3 million, down 8% compared to $24.4 million in the same period in the prior year.
Earnings, Finance
Earnings
Sight Sciences has reported cash and cash equivalents of $79.8 million at the end of Q2 2026, compared to $85 million at the end of Q1 2026, with cash used in the quarter including a one-time $5.4 million success fee payment related to the Alcon litigation, partially offset by $1.6 million in tariff refunds, resulting in underlying cash usage of $1.4 million, down 81% from $7.3 million in Q2 2025.
Earnings, Accounting, Lawsuits, Legal Affairs, Financial Reporting, Finance
Earnings
Sight Sciences has provided Q3 2026 guidance implying total revenue growth in the mid to high teens compared to the prior year, with Interventional Glaucoma expected to grow in the mid-single digits and Interventional Dry Eye revenue expected to be approximately $3 million.
Earnings, Finance
Earnings
Earnings, Accounting, Financial Reporting, Finance
Sight Sciences News & Media
TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease
MENLO PARK, Calif., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative interventional technologies intended to transform care and improve patients' lives, today announced that, effective August 18, 2026, the U.S. Food and Drug Administration (FDA) updated the TearCare® System (TearCare) Indications for Use to state:Sight Sciences (SGHT) names new Chief Legal Officer and grants $1.4M RSUs - Stock Titan
Sight Sciences appoints Kashif Rashid as Chief Legal Officer with a $450,000 salary, 50% target bonus and $1.4M RSU grant, while outgoing CLO Jeremy Hayden receives one year salary and COBRA benefits under a separation arrangement.Sight Sciences Reports Second Quarter 2026 Financial Results
Raises Full-Year 2026 Revenue Guidance and Reduces Adjusted Operating Expense Guidance Raises Full-Year 2026 Revenue Guidance and Reduces Adjusted Operating Expense Guidance
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sight Sciences
Sign Up For FreeTo access detailed company insights
Sight Sciences Inc. is an ophthalmic medical device company. It engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company was founded in 2010 and is headquartered in Menlo Park, California.... Read More
